NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.010
+0.010 (1.00%)
Nov 4, 2026, 1:16 PM EST - Market open
NuCana Market Cap
NuCana has a market cap or net worth of $4.35 million as of November 4, 2026. It is the 45,436th most valuable company in the world and the 6,053rd biggest in the United States. Its market cap has decreased by 43.47% in one year.
Market Cap
4.35M
Enterprise Value
-20.63M
1-Year Change
-43.47%
Global Rank
Country Rank
#6,053 United States
Category
ChartMarket Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $4.35M, a decrease of -99.15%. That is a compound annual growth rate of -40.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 4.20M | -72.00% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 5.11M |
| Imunon | 5.11M |
| Can-Fite BioPharma | 5.08M |
| Alaunos Therapeutics | 4.95M |
| Cardio Diagnostics Holdings | 4.94M |
| Xenetic Biosciences | 4.80M |
| AIM ImmunoTech | 4.70M |
| Azitra | 4.66M |